Effects of program for promoting self- management of poor appetite in older people with chronic kidney disease

Chronic Kidney Disease prevention in the Northeast of Thailand (CKDNET)0 sites54 target enrollmentJuly 7, 2021

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: older people with chronic kidney disease (CKD)
Sponsor: Chronic Kidney Disease prevention in the Northeast of Thailand (CKDNET)
Enrollment: 54
Status: Not yet recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

July 7, 2021

End Date

December 31, 2021

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

Chronic Kidney Disease prevention in the Northeast of Thailand (CKDNET)

•1\) age 60 years or over
•2\) diagnosed with chronic kidney disease stage 4\-5
•(eGFR 1\-29\) with no renal replacement therapy
•3\) Receive treatment at the outpatient department Phimai Hospital, Phimai District, Nakhon Ratchasima Province
•4\) Experienced anorexia at least once in the past 1 month with an anorexia score of 4 or more. Anorexia score will be measured using a screening form for anorexia symptoms: numeric scale from 0 (no anorexia) to 10 (most anorexia).
•5\) Able to understand and communicate using Thai or local language
•6\) No symptoms of depression, which will be measure using the two\-question (2Q) depression screening questionnaire, with a 'no' answer for both items. If there is 'yes' answer to either of the items. The researcher continued the assessment with a 9\-question (9Q) depression screening form (Department of Mental Health, Ministry of Public Health, 2014\) with a total score of less than 7 points.
•7\) No cognitive impairment, which will be assessed with the Abbreviated Mental Test (AMT) (Department of Medicine, Ministry of Public Health, 2014\) with more than 7 correct answers.
•8\) No vision or hearing problems
•9\) Willing to participate in the research

•1\) Unable to participate in all activities during the program
•2\) Experience symptoms (such as feeling tired, palpitations, chest discomfort, shortness of breath) while participating in the program; and/ or have abnormal vital signs (the normal range of vital signs are as follows: pulse 60\-100 beats per minute, respiratory rate 12\-20 beats per minute, blood pressure 90\-180 mmhg/ 60\-120 mmhg .
•3\) Receive any form of renal replacement therapy ( hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD)) during the program.
•4 ) Be referred to another hospital for treatment.
•5\) Appetite stimulant drugs used during the study.